Wasel, Norman
Thaçi, Diamant
French, Lars E.
Conrad, Curdin
Dutronc, Yves
Gallo, Gaia
Berggren, Lovisa
Lacour, Jean-Philippe
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
https://doi.org/10.1007/s13555-020-00383-x
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
https://doi.org/10.1007/s40744-023-00553-1
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
https://doi.org/10.1007/s13555-022-00704-2
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 5 March 2020
First Online: 15 May 2020